日本語フィールド
著者：*Masayuki Maeda, Yuichi Muraki, Tadashi Kosaka, Takehiro Yamada, Yosuke Aoki, Mitsuo Kaku, Masafumi Seki, Yoshinari Tanabe, Naohisa Fujita, Yoshihito Niki, Kunihiko Morita, Katsunori Yanagihara, Koichiro Yoshida, Tatsuya Kawaguchi題名：Impact of health policy on structural requisites for antimicrobial stewardship: A nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs 発表情報：J Infect Chemother 巻: 27 号: 1 ページ: 1-6キーワード：Additional reimbursement; Antimicrobial stewardship; Full-time equivalent; Health policy; Japan; Survey概要：Declaration of competing interest Yuichi Muraki received speaker honoraria from Pfizer Japan, Inc. Masafumi Seki received speaker honoraria from Daiichi Sankyo Co., Ltd., MSD, Japan, Pfizer Japan, Inc. as well as research grants from Astellas Pharma, Inc., Shionogi & Co., Ltd. Katsunori Yanagihara received speaker honoraria from Pfizer Japan, Inc., Daiichi Sankyo Co., Ltd., Astellas Pharma, Inc., Taisho Toyama Pharmaceutical Co., Ltd., Asahi Kasei Pharma Co., Ltd., and BD Japan; research fees from Taisho Toyama Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., and Roche Diagnostics K.K.; and research grants from Dainippon Sumitomo Pharma Co., Ltd., MSD K.K., Daiichi Sankyo Co., Ltd., Astellas Pharma, Inc., Pfizer Japan, Inc., Taisho Toyama Pharmaceutical Co., Ltd., and Biofermin Seiyaku Co., Ltd. Koichiro Yoshida received speaker honoraria from MSD K.K. and Pfizer Japan, Inc. Yoshihito Niki received speaker honoraria from Pfizer Japan Inc., Astellas Pharma Inc., Taisho Toyama Pharmaceutical Co., Ltd., MSD K.K., Dainippon Sumitomo Pharma Co., Ltd., Asahikasei Pharma Corporation, Meiji Seika Pharma Co., Ltd., Daiichi Sankyo Co., Ltd., and research grants from Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., MSD K.K., Astellas Pharma Inc., and Shionogi & Co., Ltd. Yoshihito Niki is endowed chairs and funded by Shionogi & Co., Ltd., Meiji Seika Pharma Co., Ltd., Fujifilm Co., Ltd., Daiichi Sankyo Co., Ltd., Astellas Pharma Inc., Kyorin Pharmaceutical Co., Ltd., and Toyama Chemical Co., Ltd.抄録：英語フィールド
Author：*Masayuki Maeda, Yuichi Muraki, Tadashi Kosaka, Takehiro Yamada, Yosuke Aoki, Mitsuo Kaku, Masafumi Seki, Yoshinari Tanabe, Naohisa Fujita, Yoshihito Niki, Kunihiko Morita, Katsunori Yanagihara, Koichiro Yoshida, Tatsuya KawaguchiTitle：Impact of health policy on structural requisites for antimicrobial stewardship: A nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs Announcement information:J Infect Chemother Vol: 27 Issue: 1 Page: 1-6Keyword：Additional reimbursement; Antimicrobial stewardship; Full-time equivalent; Health policy; Japan; SurveyAn abstract：Declaration of competing interest Yuichi Muraki received speaker honoraria from Pfizer Japan, Inc. Masafumi Seki received speaker honoraria from Daiichi Sankyo Co., Ltd., MSD, Japan, Pfizer Japan, Inc. as well as research grants from Astellas Pharma, Inc., Shionogi & Co., Ltd. Katsunori Yanagihara received speaker honoraria from Pfizer Japan, Inc., Daiichi Sankyo Co., Ltd., Astellas Pharma, Inc., Taisho Toyama Pharmaceutical Co., Ltd., Asahi Kasei Pharma Co., Ltd., and BD Japan; research fees from Taisho Toyama Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., and Roche Diagnostics K.K.; and research grants from Dainippon Sumitomo Pharma Co., Ltd., MSD K.K., Daiichi Sankyo Co., Ltd., Astellas Pharma, Inc., Pfizer Japan, Inc., Taisho Toyama Pharmaceutical Co., Ltd., and Biofermin Seiyaku Co., Ltd. Koichiro Yoshida received speaker honoraria from MSD K.K. and Pfizer Japan, Inc. Yoshihito Niki received speaker honoraria from Pfizer Japan Inc., Astellas Pharma Inc., Taisho Toyama Pharmaceutical Co., Ltd., MSD K.K., Dainippon Sumitomo Pharma Co., Ltd., Asahikasei Pharma Corporation, Meiji Seika Pharma Co., Ltd., Daiichi Sankyo Co., Ltd., and research grants from Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., MSD K.K., Astellas Pharma Inc., and Shionogi & Co., Ltd. Yoshihito Niki is endowed chairs and funded by Shionogi & Co., Ltd., Meiji Seika Pharma Co., Ltd., Fujifilm Co., Ltd., Daiichi Sankyo Co., Ltd., Astellas Pharma Inc., Kyorin Pharmaceutical Co., Ltd., and Toyama Chemical Co., Ltd.